A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Roger Cohen, MD
University of Pennsylvania
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Highlands Oncology Group
Rogers, Arkansas, United States
- University of California San Diego
La Jolla, California, United States
- University of California at Los Angeles
Los Angeles, California, United States
- University of California Davis
Sacramento, California, United States
- Georgia Regents University
Augusta, Georgia, United States
- University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, United States
- University of Massachusetts
Worcester, Massachusetts, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Suny Syracuse
Syracuse, New York, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Providence Portland Medical Center- Providence Lung Cancer Clinic
Portland, Oregon, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Texas Oncology Pa Texas Cancer Center
Abilene, Texas, United States
- Mary Crowley Cancer Center
Dallas, Texas, United States
- Cancer Care Northwest
Spokane, Washington, United States
- Aurora Research Institute
Green Bay, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2014
- Primary completion
- 31 Dec 2017
- Completion
- 30 Apr 2018
- Last update posted
- 5 Feb 2020
- Registered enrollment
- 66
- Registry id
- NCT02117024
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.